Rank F, Dombernowsky P, Jespersen N C, Pedersen B V, Keiding N
Cancer. 1987 Sep 15;60(6):1299-305. doi: 10.1002/1097-0142(19870915)60:6<1299::aid-cncr2820600623>3.0.co;2-l.
In a prospective adjuvant trial including patients with primary operable breast cancer, invasive carcinomas of ductal type were subjected to histological malignancy grading. The parameters investigated were tubule formation, number of mitoses and cell pleomorphism. A Cox regression model for survival data was applied to evaluate the impact of the histological parameters on prognosis in 1809 patients with low-risk carcinomas. Cell pleomorphism proved superior to the other histologic tumor characteristics. It was found that low-risk invasive ductal carcinomas with severe cell pleomorphism had an excess recurrence intensity of 209% relative to carcinomas with no pleomorphism. It is therefore suggested that polymorphous invasive ductal breast carcinomas, other things being equal, should be regarded as high-risk tumors in future clinical trials. Finally it was found that the tripartite malignancy grading 1, 2 and 3 characterizing each of the histological parameters was not equidistant. Consequently, the traditional tripartite histologic scoring needs reconsideration.
在一项针对原发性可手术乳腺癌患者的前瞻性辅助试验中,对导管型浸润癌进行了组织学恶性分级。所研究的参数包括小管形成、有丝分裂数和细胞多形性。应用生存数据的Cox回归模型来评估组织学参数对1809例低风险癌患者预后的影响。结果表明,细胞多形性优于其他组织学肿瘤特征。研究发现,与无细胞多形性的癌相比,具有严重细胞多形性的低风险浸润性导管癌的复发强度高出209%。因此,建议在未来的临床试验中,在其他条件相同的情况下,多形性浸润性导管乳腺癌应被视为高风险肿瘤。最后发现,表征每个组织学参数的1、2和3级三方恶性分级并非等距。因此,传统的三方组织学评分需要重新考虑。